- Product Details
Keywords
- Linaelotide
- Linaelotide Acetate
- Peptide high quality low price in stock
Quick Details
- ProName: linaclotide 98% high quality low price...
- CasNo: 851199-59-2
- Molecular Formula: C59H79N15O21S6
- Appearance: White powder
- Application: Research USE
- DeliveryTime: In stock or 2-3day
- PackAge: Foil bag
- Port: HongKong or other
- ProductionCapacity: 10 Kilogram/Month
- Purity: 98(%)
- Storage: Closed, - 2 ~ - 8℃ preservation.
- Transportation: Fedex,EMS,UPS,TNT,DHL
- LimitNum: 20 Milligram
Superiority
Item |
Specification |
Specific rotation |
+39.5 to +41.5° |
State of solution(transmittance) |
Clear 98.0% min. |
Chloride[cl] |
0.020% max. |
Ammonium [NH4] |
0.02% max. |
Sulfate[SO4] |
0.020% max |
Iron[Fe] |
10ppm max. |
Heavy metals [Pb] |
10ppm max |
Arsenic[As2O3] |
1ppm max |
Other amino acids |
Chromatographically not detectable |
Loss on drying |
0.20% max. |
Residue on ignition[sulfated] |
0.10% max. |
Assay |
99.0% min |
Shipping
Details
Description
In August 2012, the US FDA approved linaclotide (also referred to as MD-1100), a first-in-class, orally administered 14-amino acid peptide as a therapy for patients suffering from chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Linaclotide and its active metabolite MM-419447, which results from the cleavage of the C-terminal tyrosine residue by carboxypeptidase A, mimic the actions of the endogenous intestinal peptides guanylin (15 amino acids) and uroguanylin (16 amino acids) by activating guanylyl cyclase C (GC-C) on the intestinal epithelium. Activation of GC-C leads to increased intra- and extracellular levels of cGMP and activation of the CFTR ion channel, resulting in increased levels of HCO3-, Cl-, and water in the intestinal lumen and accelerated gastrointestinal transit. Based on an in vitro assaymeasuring the accumulation of cGMP in T84 cell exposed to an agonist, the EC50 of linaclotide at pH 7.0 was 99±17.5 nM. In preclinical studies in mice using the transit of activated charcoal as ameasure of efficacy, linaclotide at 100 μg/kg significantly accelerated transit compared to wild-type mice treated with charcoal only or GC-Cnullmice treatedwith and without linaclotide.118 Efficacy was also seen in rats treatedwith linaclotide atdoses of 5, 10, and 20 μg/kg. Linaclotide has been synthesized using conventional solid-phase peptide technology.
Changzhou Xuanming Chemical Co., Ltd. is dedicated to the technology development, manufacturing, import and export chemicals, which are specialized in pharmaceutical intermediates, pesticide intermediate, industry of fine chemicals and custom synthesis. Now, we enjoy good reputation among customers and take favorable market share in domestic and at abroad.
Changzhou Xuanming Chemical CO., LTD is located in Northern Jiangshu Industry Park, we have modern manufacture bases and some laboratories, which can supply the key intermediate for your projects, and short your synthesis scheme and supply you a reference compound for bioassay or a high purity analytical standard. We have been abided by “treat technology as first, quality as basis, customers as God, and be honest and sincere”. It is our final aim to provide environmental and high technological products and meet customers’ requirements according to keep effors on developing new chemical fields.
Changzhou Xuanming Chemical CO., LTD promises to help you with heart and soul.